The predominant CD44 splice variant in prostate cancer binds fibronectin, and calcitonin stimulates its expression. Anticancer Res 2006;26(4B):2863-72
Date
08/05/2006Pubmed ID
16886606Scopus ID
2-s2.0-33746731655 (requires institutional sign-in at Scopus site) 21 CitationsAbstract
BACKGROUND: Prostate cancer (PC) consistently overexpresses variant the (v) isoform of the cell adhesion protein CD44, and loses expression of the standard (s) isoform.
MATERIALS AND METHODS: We re-expressed CD44 full-length (exons 1-20) or standard (exons 1-5 + 16-20) or enforced stable RNAi against CD44v, and the examined functional effects on PC. The effect of stable knockout of calcitonin, a paracrine factor, or its receptor, on CD44 was assessed.
RESULTS: Re-expression of full-length CD44 or CD44s increased the total CD44 mRNA and CD44s protein while suppressing CD44v. These approaches, and RNAi to CD44v, decreased invasion. In adhesion assays, benign prostate cells bound mainly to hyaluronan, whereas PC lost affinity for hyaluronan but bound more strongly to fibronectin. Re-expressing CD44s restored predominant hyaluronan binding. Knockout of the calcitonin receptor in PC-3 derived cells caused marked loss of CD44v expression and reversion to CD44s expression.
CONCLUSION: Calcitonin influenced PC's balance between CD44s and CD44v. CD44v controlled invasiveness, altered ligand binding, and provides a target for therapeutic intervention.
Author List
Iczkowski KA, Omara-Opyene AL, Shah GVMESH terms used to index this publication - Major topics in bold
Alternative SplicingCalcitonin
Cell Adhesion
Cell Line, Tumor
Fibronectins
Gene Silencing
Humans
Hyaluronan Receptors
Male
Prostatic Neoplasms
Protein Isoforms
RNA, Messenger
RNA, Small Interfering
Receptors, Calcitonin
